Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-22

FDA Approved: NATEGLINIDE — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

The FDA granted a supplemental approval for Nateglinide from Zydus Lifesciences Limited under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nateglinide (nateglinide)

Snippet

SUPPL AP for NATEGLINIDE (NATEGLINIDE)